Trial
NCT02369900
Esmolol to Treat the Hemodynamic Effects of Septic Shock
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
American Heart Association
Condition
Septic Shock
Intervention
Esmolol
Why stopped
Funding expired, low enrollments
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-28